Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in Columbia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies against AChR or MuSK, administered twice a day (BID) for 21 days.
Sponsor: NMD Pharma A/S
Check if you qualify for this myasthenia gravis clinical trial in Columbia, MO
If you're searching for myasthenia gravis treatment options in Columbia, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.